Navigation Links
Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease
Date:12/8/2010

CRANBURY, N.J., Dec. 8, 2010 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company focused on developing treatments for rare diseases, today announced that it has been awarded a second grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) for the development of a novel, next-generation pharmacological chaperone for the treatment of Parkinson's disease.  The $500,000 award will be distributed over a period of 24 months. Amicus' studies will be conducted in collaboration with Marie-Francoise Chesselet, M.D., Ph.D. the Charles H. Markham Professor of Neurology and Chair, Department of Neurobiology, David Geffen School of Medicine at UCLA.  

"We are honored to receive this grant from the MJFF, which will help us further develop our novel treatment for Parkinson's disease," said David J. Lockhart, Ph.D., Amicus Therapeutics' Chief Scientific Officer.  "Currently available treatments for Parkinson's provide symptomatic relief only. Our therapy is designed to address a deficiency that is inherited in a subset of the Parkinson's population, and to actually modify the course of the disease.  The targeted compounds that we have discovered have shown promising effects in initial animal studies, and we are delighted to be working together with the MJFF and Dr. Chesselet to advance our lead compound into advanced preclinical studies."

The studies will focus on the Parkinson's-implicated protein alpha-synuclein. Accumulation of alpha-synuclein in the nervous system is a hallmark of Parkinson's disease. Amicus is working on a strategy to reduce levels of synuclein in the brain, in the hope that this would lessen the changes in the brain seen in Parkinson's disease -- such as loss of the neurotransmitter dopamine -- and resulting behavioral changes.    

"I am pleased to continue working with Amicus on th
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
2. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
4. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
5. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
6. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
7. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
8. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
9. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
10. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
11. Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... MEADOWS, N.Y. , Dec. 15, 2014 ... the SPL (Structured Product Labeling) markup language standard, content ... the understanding and skills to work with the standard. ... a series of three webinars on the benefits and ... three one-hour webinars will be facilitated by Howard ...
(Date:12/15/2014)... , Dec. 15, 2014  The Government of Ghana ... AABB, Global Blood Fund (GBF) and Terumo BCT to respond to ... as well as provide long-term health system capacity to the citizens ... , The Ghanaian Ebola Readiness and Resilience Initiative (GERRI) is ... preparations for the possible arrival of the Ebola epidemic ...
(Date:12/13/2014)... Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ... "Drug Injection Devices to 2020" report to ... As new drugs become available ... health conditions, drug developers have increasingly pursued packaging ... and increase the efficiency and reliability with which ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... Feb. 28, 2011 Mylan Inc. (Nasdaq: MYL ... received final approval from the U.S. Food and Drug Administration ... Capsules USP, 100 mg, 300 mg and 400 mg, the ... treat a painful complication of shingles. Gabapentin ...
... SHENZHEN, China, Feb. 28, 2011 /PRNewswire-Asia/ -- Winner ... "Winner Medical"), a leading manufacturer of medical dressings, ... natural PurCotton® products in China, announced today that ... Rodman & Renshaw Annual China Investment ConferenceDate: , ...
Cached Medicine Technology:Winner Medical to Attend Investor Conferences in March 2Winner Medical to Attend Investor Conferences in March 3Winner Medical to Attend Investor Conferences in March 4
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s ... new study providing evidence on the impact of 100% ... , Sufficient enough evidence already exists showing a negative ... drinks, with the onset of tooth decay. One question ... as 100% fruit juice, meaning it is completely natural ...
(Date:12/15/2014)... 2014 SIMpalm, a leading mobile ... for iPhone for its client, which allows users to ... company, specialized in finding the right wine. At ... uses combined sensory, chemistry and wine information. All this ... “wine fingerprint.” Those wines that are close counterparts to ...
(Date:12/15/2014)... 2014 Health Dialog, a leading ... that it has received Patient Oriented Accreditation from ... its Disease Management (DM) Programs for asthma, congestive ... heart disease and diabetes. This marks the 12th ... Dialog’s Disease Management (DM) Programs, reaffirming Health Dialog’s ...
(Date:12/15/2014)... Expert pilots process visual information more efficiently than less ... during landings, a new study shows. Landing is ... master, and 36 percent of all airplane crashes and ... and landing. Researchers monitored the brain activity of ... they were at the controls of a flight simulator. ...
(Date:12/15/2014)... Kathy McAfee, America's Marketing Motivator, was announced ... the category of Best Blog 2014. McAfee received the ... career blog Networking Ahead which combines many ... their talent and influence through better networking, leadership and ... Networking Ahead for Business, has been motivating readers for ...
Breaking Medicine News(10 mins):Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... cancer cases in 2003.// Researchers have been mulling over the ... their attention. Nearly millions of women had abandoned hormone replacement ... out such a huge difference, is being debated over. ... the number of breast cancer cases, estimated at 14,000 women ...
... people with history of unprotected sex to have an ... transmission.// The announcement being the first case of such ... Thursday uncovered two clusters of HIV infections, HIV-1 subtype ... government scientists. They said that both the clusters found ...
... gas tragedy survivors' organisations claimed //to have seized a ... medical stores of the Bhopal Gas Tragedy Relief and ... organisations, working for the victims of the world's worst ... their expiry date," Rachna Dhingra of Bhopal Group of ...
... researchers at the University of Pennsylvania Health System are ... the heart when its electrical pulses// essentially short-circuit, referred ... problem physicians run into with current therapies to cope ... pulmonary vein isolation procedures, is that up until now, ...
... the limit,’ but subsequently found to be below maximum permissible ... drugs, reveals research in Injury Prevention. ,The findings ... all drivers who are suspected of being over the limit ... 2000 blood and urine specimens taken from drivers who had ...
... a man’s heart is through his stomach, they say! Is that ... for thought, of course! Meanwhile, what could be the route to ... the lady of the house, says a new study. ... study of almost 200 British men and women, who were on ...
Cached Medicine News:Health News:New Tool Being Tested to Halt Recurrence of Atrial Fibrillation 2Health News:One in Three Drivers Under ‘The Limit’ for Alcohol Still Test Positive for Dru 2Health News:How a Woman Holds Fort in Her Little Kingdom – The Kitche 2
Custom Conjugation Services...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD...
Medicine Products: